Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Study discovers link between meditation and how individuals respond to feedback

In a new study in the Journal of Cognitive, Affective & Behavioral Neuroscience researchers from the University of Surrey have discovered a link between meditation and how individuals respond to feedback.

11 Dec 2018

New study reveals yin-yang personality of dopamine

For decades, psychologists have viewed the neurotransmitter dopamine as a double-edged sword: released in the brain as a reward to train us to seek out pleasurable experiences, but also a "drug" the constant pursuit of which leads to addiction.

11 Dec 2018

Caffeine plus another compound in coffee may fight Parkinson’s disease

Rutgers scientists have found a compound in coffee that may team up with caffeine to fight Parkinson's disease and Lewy body dementia - two progressive and currently incurable diseases associated with brain degeneration.

10 Dec 2018

High-intensity interval exercise could help combat cognitive dysfunction in obese people

It's fast-paced, takes less time to do, and burns a lot of calories. High-intensity interval exercise is widely recognized as the most time-efficient and effective way to exercise.

10 Dec 2018

Mount Sinai researcher awarded $2.5 million to advance understanding of neurodegenerative diseases

Ivan Marazzi, PhD, Assistant Professor of Microbiology at the Icahn School of Medicine at Mount Sinai, was awarded $2.5 million in funding by the Chan Zuckerberg Initiative to further the understanding of the underlying causes of neurodegenerative disorders such as Lou Gehrig's, Alzheimer's, and Parkinson's diseases. The

7 Dec 2018

Vitamin D deficiency associated with increased risk of depression in older adults

A new study by researchers from The Irish Longitudinal Study on Ageing at Trinity College Dublin has shown for the first time in Ireland that a deficiency in vitamin D was associated with a substantial increased risk of depression (+75%) over a four-year follow up period.

5 Dec 2018

Combining toxic herbicide with sugar-binding proteins may trigger Parkinsonism

Combining low doses of a toxic herbicide with sugar-binding proteins called lectins may trigger Parkinsonism -- symptoms typical of Parkinson's disease like body tremors and slowing of body motions -- after the toxin travels from the stomach to the brain.

4 Dec 2018

Researchers identify promising new therapeutic target for Parkinson’s

A new study has shed light on the role fatty acids play in Parkinson’s disease and pointed towards an enzyme as a potential therapeutic target for the disease.

4 Dec 2018

Customizing Genetically Engineered Models for Specific Research Applications

In this interview conducted at SfN 2018, Philip Dubé from Taconic Biosciences, goes into detail about genetically engineered models and their importance in understanding neurodegenerative diseases.

From Taconic Biosciences, Inc. 4 Dec 2018

Latest advances in AI for aging and longevity research

Insilico Medicine, one of the leaders in artificial intelligence for drug discovery, biomarker development, digital medicine, and aging research announced today the publication of its recent paper titled "Artificial Intelligence for Aging and Longevity Research: Recent Advances and Perspectives" in Ageing Research Reviews, one of the highest-impact journals in the field.

3 Dec 2018

$Many diseases increase risk of post-operative complications after hip fracture surgery$

Many diseases increase risk of post-operative complications after hip fracture surgery

Parkinson's disease, osteoarthritis, rheumatic diseases, alcoholism and mental health disorders increase the risk of surgical complications after a hip fracture surgery, a new Finnish study analyzing nationwide registers finds.

30 Nov 2018

Insilico Medicine to present work on AI for Drug Discovery at the AI World Conference

Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its latest results in modern and next-generation AI for Drug Discovery at the AI World Conference in Boston on December 4th.

30 Nov 2018

Scientists discover important hallmark of aging in neuronal cells

MIT researchers have discovered that free radicals cause a build-up of short RNA snippets which could contribute to neuronal ageing and cognitive decline.

27 Nov 2018

Photographic aging clock uses advances in Artificial Intelligence to predict human age

There are many factors that influence the aging process. Unlocking these factors can lead to valuable insights into what impacts the condition and health of the human body and reveal how to minimize these impacts.

26 Nov 2018

Microglia show distinct responses under inflammatory conditions

The NorLux Neuro-Oncology Laboratory at LIH's Department of Oncology conducts research on brain diseases, with a special emphasis on glioma biology, drug resistance and systems approaches.

26 Nov 2018

A Preclinical Solution to Studying Neurological Diseases

At SfN 2018, Antti Nurmi explained a case study of how Charles River have used neuroimaging to study Batten's Disease.

From Charles River Labs - Neuroscience Discovery Services 26 Nov 2018

The brain uses two clocks to predict the future

That moment when you step on the gas pedal a split second before the light changes, or when you tap your toes even before the first piano note of Camila Cabello's "Havana" is struck. That's anticipatory timing.

21 Nov 2018

Cytocybernetics receives NIMH award to move into neuronal drug development

Cytocybernetics, a University at Buffalo spinoff, has received a $250,000 Small Business Innovation Research award from the National Institute of Mental Health (NIMH) to move into a new market: neuronal drug development.

20 Nov 2018

Insilico Medicine to introduce 'Cure a disease in a year' program at Biodata World Congress 2018

Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery and real world evidence pipeline utilizing the next generation artificial intelligence, will present its research and introduce the "Cure a disease in a year" program at the World's leading congress for big data in precision medicine - Biodata World Congress 2018.

19 Nov 2018

Inhibition of one protein clears toxic clumps seen in Parkinson's disease, study finds

A defining feature of Parkinson's disease is the clumps of alpha-synuclein protein that accumulate in the brain's motor control area, destroying dopamine-producing neurons.

14 Nov 2018